456 related articles for article (PubMed ID: 7538847)
1. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding.
Hammacher A; Ward LD; Weinstock J; Treutlein H; Yasukawa K; Simpson RJ
Protein Sci; 1994 Dec; 3(12):2280-93. PubMed ID: 7538847
[TBL] [Abstract][Full Text] [Related]
2. Role of the C-terminus in the activity, conformation, and stability of interleukin-6.
Ward LD; Hammacher A; Zhang JG; Weinstock J; Yasukawa K; Morton CJ; Norton RS; Simpson RJ
Protein Sci; 1993 Sep; 2(9):1472-81. PubMed ID: 8401231
[TBL] [Abstract][Full Text] [Related]
3. Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin.
McWherter CA; Feng Y; Zurfluh LL; Klein BK; Baganoff MP; Polazzi JO; Hood WF; Paik K; Abegg AL; Grabbe ES; Shieh JJ; Donnelly AM; McKearn JP
Biochemistry; 1999 Apr; 38(14):4564-71. PubMed ID: 10194378
[TBL] [Abstract][Full Text] [Related]
4. Identification of two novel regions of human IL-6 responsible for receptor binding and signal transduction.
Ehlers M; Grötzinger J; deHon FD; Müllberg J; Brakenhoff JP; Liu J; Wollmer A; Rose-John S
J Immunol; 1994 Aug; 153(4):1744-53. PubMed ID: 7519211
[TBL] [Abstract][Full Text] [Related]
5. Roles of histidine 31 and tryptophan 34 in the structure, self-association, and folding of murine interleukin-6.
Matthews JM; Ward LD; Hammacher A; Norton RS; Simpson RJ
Biochemistry; 1997 May; 36(20):6187-96. PubMed ID: 9166791
[TBL] [Abstract][Full Text] [Related]
6. Analysis of human/mouse interleukin-6 hybrid proteins: both amino and carboxy termini of human interleukin-6 are required for in vitro receptor binding.
Fiorillo MT; Cabibbo A; Iacopetti P; Fattori E; Ciliberto G
Eur J Immunol; 1992 Oct; 22(10):2609-15. PubMed ID: 1396966
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3.
Feng Y; Klein BK; McWherter CA
J Mol Biol; 1996 Jun; 259(3):524-41. PubMed ID: 8676386
[TBL] [Abstract][Full Text] [Related]
8. Folding topologies of human interleukin-6 and its mutants as studied by NMR spectroscopy.
Nishimura C; Watanabe A; Gouda H; Shimada I; Arata Y
Biochemistry; 1996 Jan; 35(1):273-81. PubMed ID: 8555185
[TBL] [Abstract][Full Text] [Related]
9. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.
Toniatti C; Cabibbo A; Sporena E; Salvati AL; Cerretani M; Serafini S; Lahm A; Cortese R; Ciliberto G
EMBO J; 1996 Jun; 15(11):2726-37. PubMed ID: 8654370
[TBL] [Abstract][Full Text] [Related]
10. Identification of regions within the third FnIII-like domain of the IL-5Ralpha involved in IL-5 interaction.
Czabotar PE; Holland J; Sanderson CJ
Cytokine; 2000 Jul; 12(7):867-73. PubMed ID: 10880230
[TBL] [Abstract][Full Text] [Related]
11. Expression and in vitro properties of guinea pig IL-5: comparison to human and murine orthologs.
Scott CW; Budzilowicz C; Hubbs SJ; Stein M; Sobotka-Briner C; Wilkins DE
Mediators Inflamm; 2000; 9(3-4):181-7. PubMed ID: 11132776
[TBL] [Abstract][Full Text] [Related]
12. Circular permutation of granulocyte colony-stimulating factor.
Feng Y; Minnerly JC; Zurfluh LL; Joy WD; Hood WF; Abegg AL; Grabbe ES; Shieh JJ; Thurman TL; McKearn JP; McWherter CA
Biochemistry; 1999 Apr; 38(14):4553-63. PubMed ID: 10194377
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the disulfide bonds of recombinant murine interleukin-6 induces formation of a partially unfolded state.
Zhang JG; Matthews JM; Ward LD; Simpson RJ
Biochemistry; 1997 Mar; 36(9):2380-9. PubMed ID: 9054543
[TBL] [Abstract][Full Text] [Related]
14. [A turning point in the knowledge of the structure-function-activity relations of elastin].
Alix AJ
J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
[TBL] [Abstract][Full Text] [Related]
15. Cyclic peptide interleukin 5 antagonists mimic CD turn recognition epitope for receptor alpha.
Ruchala P; Varadi G; Ishino T; Scibek J; Bhattacharya M; Urbina C; Ryk DV; Uings I; Chaiken I
Biopolymers; 2004 Apr; 73(5):556-68. PubMed ID: 15048779
[TBL] [Abstract][Full Text] [Related]
16. Structure-function analysis of the C-terminal segment of human interleukin-6.
Li X; Rock F; Chong P; Cockle S; Keating A; Ziltener H; Klein M
J Biol Chem; 1993 Oct; 268(30):22377-84. PubMed ID: 7693665
[TBL] [Abstract][Full Text] [Related]
17. Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells.
Halimi H; Eisenstein M; Oh JW; Revel M; Chebath J
Eur Cytokine Netw; 1995; 6(3):135-43. PubMed ID: 8589270
[TBL] [Abstract][Full Text] [Related]
18. Topology of receptor binding domains of mouse IFN-gamma.
Jarpe MA; Johnson HM
J Immunol; 1990 Nov; 145(10):3304-9. PubMed ID: 1700005
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophin-3 acquires NGF-like activity after exchange to five NGF amino acid residues: molecular analysis of the sites in NGF mediating the specific interaction with the NGF high affinity receptor.
Kullander K; Ebendal T
J Neurosci Res; 1994 Oct; 39(2):195-210. PubMed ID: 7837289
[TBL] [Abstract][Full Text] [Related]
20. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.
Donaldson DD; Whitters MJ; Fitz LJ; Neben TY; Finnerty H; Henderson SL; O'Hara RM; Beier DR; Turner KJ; Wood CR; Collins M
J Immunol; 1998 Sep; 161(5):2317-24. PubMed ID: 9725226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
